ClinicalTrials.gov
public full text
Public Domain
Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
The purpose of this large multicenter, randomized, double-blinded, controlled clinical study is to investigate the efficacy and safety of Cyclosporin A for primary Sjogren's syndrome associated pneumonitis(pSS-IP), which has important implications for the establishment of standardized diagnosis and treatment of pSS-IP.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Interstitial Lung Diseases in Primary Sjogren's Syndrome#1150471
- Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone#126089
- Implantology and Sjögren's Syndrome#915193
- Inflammatory Myopathies in Primary Sjögren's Syndrome#904885
- Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma#1126071
Record · ID 911107
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive